Armonica Technologies
Armonica Technologies: Innovating precision medicine with proprietary long-read DNA sequencing tech.
Founded
2015Armonica Technologies: Innovating precision medicine with proprietary long-read DNA sequencing tech.
Armonica Technologies, founded as an early-stage medtech company, is dedicated to advancing precision medicine through its proprietary long-read DNA sequencing technology. The company's core mission is to revolutionize genetic analysis by utilizing nanochannels to guide single DNA molecules through nanopores, which are then optically read using Raman spectroscopy. This innovative approach aims to provide more accurate and comprehensive genetic information, targeting applications in precision medicine and epigenetic sequencing.
Notable figures affiliated with Armonica Technologies include leading experts in genomics and biotechnology, though specific names are not provided. The company has attracted significant interest from investors focused on cutting-edge medical technologies. Key achievements include the development of their unique sequencing platform, which promises to enhance the accuracy and depth of genetic data analysis. Armonica Technologies' impact lies in its potential to transform personalized medicine, offering more precise diagnostic and therapeutic options for various genetic conditions.
Companies similar to Armonica Technologies include Ontera, XGenomes, Quantapore and Sequegenics.
Armonica Technologies was founded in 2015.
Armonica Technologies' headquarters is located in Carlsbad, CA, US.
Armonica Technologies' most recent funding round was for $2M (USD) in August 2022.
As of Aug 31, 2022, Armonica Technologies has raised a total of $5.8M (USD).
Armonica Technologies has 7 employees as of Feb 4, 2024.
Quantapore
